Skip to main content
. 2017 Jul 6;8:442. doi: 10.3389/fphar.2017.00442

Table 2.

Extent and duration of anti-allodynia (ΔPWT AUC) and potencies of test compounds.

ED50 for the alleviation of mechanical allodynia in the bilateral hindpaws (mg/kg)
Time (h)
Mean ΔPWT at peak effect (g)
ΔPWT AUC (g.h)
Ipsilateral
Contralateral
Test compound and route of administration Peak effect ~Duration of action Ipsi Contra Ipsi Contra Mean 95% CI Mean 95% CI
Morphine (s.c.)
0.3 mg/kg 0.5–0.75 2 1.9 (±0.76) 2.2 (±1.07) 3.7 (±0.88) 3.9 (±1.28) 1.3 0.90–1.83 1.4 0.98–2.08
1 mg/kg 4.1 (±0.70) 4.2 (±0.72) 4.7 (±0.38) 4.8 (±0.49)
3 mg/kg 6.9 (±1.00) 6.2 (±0.72) 9.6 (±1.22) 10.2 (±1.28)
Vehicle NA NA 1.8 (±0.44) 2.2 (±0.38)
Gabapentin (i.p.)
30 mg/kg 1.25–1.5 >3 2.6 (±0.83) 2.4 (±0.78) 4.5 (±0.73) 4.5 (±0.61) 47.1 35.25–63.04 30.8 21.9–43.2
70 mg/kg 3.7 (±0.61) 3.7 (±0.68) 6.8 (±0.46) 7.5 (±0.63)
100 mg/kg 4.1 (±0.70) 4.1 (±0.58) 8.4 (±1.08) 8.3 (±0.83)
Vehicle NA NA 2.0 (±0.43) 3.0 (±0.76)
Amitriptyline (i.p.)
3 mg/kg 0.75–1.25 2 2 (±0.81) 2.1 (±0.78) 2.6 (±0.80) 2.6 (±0.75) 20.1 13.82–29.11 21.4 14.27–32.19
10 mg/kg 3.3 (±0.99) 2.8 (±0.78) 4.5 (±0.89) 4.0 (±0.99)
30 mg/kg 5.8 (±1.15) 4.9 (±0.89) 7.8 (±1.28) 7.4 (±1.42)
Vehicle NA NA 1.4 (±0.45) 1.7 (±0.27)
Meloxicam (i.p.)
2.5 mg/kg 1.25–1.5 >3 2.6 (±0.83) 2.2 (±0.66) 4.5 (±0.67) 4.5 (±0.65) 3.9 2.79–5.43 3.5 2.51–4.79
5 mg/kg 4.3 (±0.45) 4.3 (±0.45) 8.1 (±1.07) 8.2 (±1.00)
7.5 mg/kg 6.1 (±0.96) 5.3 (±0.62) 11.5 (±1.22) 10.3 (±1.04)
Vehicle NA NA 1.8 (±0.64) 2.0 (±0.68)

CI, confidence interval; Contra., contralateral hindpaws; Ipsi., ipsilateral hindpaws; NA, not applicable; p ≤ 0.05 (One-way ANOVA, post hoc Dunnett’s multiple comparisons test) c.f. rats that received single bolus doses of vehicle.